New Therapeutic Strategies Promoting Resolution of Inflammation

Johnson & Johnson Innovation is seeking therapeutic targets and/or therapeutic assets targeting pathways driving pro-resolution responses in innate immune cells. Specifically, the identification and assessment of therapeutic targets and pathways that drive pro-resolution responses in innate immune cells that can be used to treat autoimmune and/or chronic inflammatory diseases.

Specific Processes of Interest

• Cessation of neutrophil tissue infiltration
• Counter-regulation of chemokines and cytokines
• Induction of apoptosis in spent neutrophils while promoting...